WebThe Caraway family name was found in the USA, the UK, Canada, and Scotland between 1840 and 1920. The most Caraway families were found in USA in 1880. In 1840 there … WebThe compounds of formula (I) are useful in the treatment TRPML1- mediated disorders or diseases. WO2024094974A1 - Heterocyclic trpml1 agonists - Google Patents Heterocyclic trpml1 agonists Download PDF Info Publication number WO2024094974A1. WO2024094974A1 PCT ...
Martin Williams on LinkedIn: Caraway Therapeutics to Present at …
WebJan 31, 2024 · “By agonizing TRPML1, we aim to restore the activity of the lysosome and improve cell health,” said Magdalene Moran, chief scientific officer at Caraway. Earlier … WebOct 7, 2024 · Caraway’s Chief Executive Officer, Martin D. Williams, will present recent advances in the Company’s TRPML1 program at the Fall Life Sciences Private Company Showcase, co-hosted by BMO Capital Markets, Solebury Strategic Communications and Goodwin in New York, NY on October 13, 2024, from 4:20pm-4:40pm ET. peekskill train schedule to grand central
Caraway Therapeutics to Present at 22nd Annual Needham …
WebJul 19, 2024 · Caraway Therapeutics. is developing a TRPML1 agonist, initially for a genetic form of Parkinson’s disease, GBA-Parkinson’s disease. They are still in early preclinical … WebJun 14, 2024 · Under this exclusive collaboration and option agreement, Caraway — a portfolio company of AbbVie Ventures — will receive an upfront payment of $17 million.. Upon meeting certain preclinical research and development milestones, Caraway will grant AbbVie an option to license the program and proceed into investigational, new drug … WebCaraway is developing proprietary small molecule TRPML1 modulators for the treatment of GBA-PD and other neurodegenerative diseases. TRPML1 Modulators for Genetically-defined Rare Diseases Many genetically … peekskill weather ny